BRIEF-Oramed And Lifeward Announce Strategic Transaction

Reuters01-13

Jan 13 (Reuters) - Lifeward Ltd 2RW.MU:

ORAMED AND LIFEWARD ANNOUNCE STRATEGIC TRANSACTION
ORAMED PHARMACEUTICALS INC - TO RECEIVE 49.9% OWNERSHIP IN LIFEWARD
ORAMED PHARMACEUTICALS INC - MARK GRANT TO LEAD COMBINED PLATFORMS
ORAMED PHARMACEUTICALS INC - LIFEWARD TO ISSUE $10 MILLION CONVERTIBLE NOTES
ORAMED PHARMACEUTICALS INC - WILL RECEIVE 4% ON NET SALES OF REWALK FRANCHISE FOR UP TO 10 YEARS

Source text: ID:nPnwV5H2a

Further company coverage: 2RW.MU

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2603681489?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-01-13 20:59","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2603681489","market":"us","top_or_hot":-1,"title":"BRIEF-Oramed And Lifeward Announce Strategic Transaction","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-Oramed And Lifeward Announce Strategic Transaction</title></head><body><p><span>Jan 13 (Reuters)</span><span> - </span><a href=\"https://laohu8.com/S/LFWD\">Lifeward Ltd</a> <span>2RW.MU</span>:</p><ul><li><p>ORAMED AND LIFEWARD ANNOUNCE STRATEGIC TRANSACTION</p></li><li><p>ORAMED PHARMACEUTICALS INC - TO RECEIVE 49.9% OWNERSHIP IN LIFEWARD</p></li><li><p>ORAMED PHARMACEUTICALS INC - MARK GRANT TO LEAD COMBINED PLATFORMS</p></li><li><p>ORAMED PHARMACEUTICALS INC - LIFEWARD TO ISSUE $10 MILLION CONVERTIBLE NOTES</p></li><li><p>ORAMED PHARMACEUTICALS INC - WILL RECEIVE 4% ON NET SALES OF REWALK FRANCHISE FOR UP TO 10 YEARS</p></li></ul><p>Source text: <span>ID:nPnwV5H2a</span></p><p>Further company coverage: <span>2RW.MU</span></p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-Oramed And Lifeward Announce Strategic Transaction</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-Oramed And Lifeward Announce Strategic Transaction\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2026-01-13 20:59</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-Oramed And Lifeward Announce Strategic Transaction</title></head><body><p><span>Jan 13 (Reuters)</span><span> - </span><a href=\"https://laohu8.com/S/LFWD\">Lifeward Ltd</a> <span>2RW.MU</span>:</p><ul><li><p>ORAMED AND LIFEWARD ANNOUNCE STRATEGIC TRANSACTION</p></li><li><p>ORAMED PHARMACEUTICALS INC - TO RECEIVE 49.9% OWNERSHIP IN LIFEWARD</p></li><li><p>ORAMED PHARMACEUTICALS INC - MARK GRANT TO LEAD COMBINED PLATFORMS</p></li><li><p>ORAMED PHARMACEUTICALS INC - LIFEWARD TO ISSUE $10 MILLION CONVERTIBLE NOTES</p></li><li><p>ORAMED PHARMACEUTICALS INC - WILL RECEIVE 4% ON NET SALES OF REWALK FRANCHISE FOR UP TO 10 YEARS</p></li></ul><p>Source text: <span>ID:nPnwV5H2a</span></p><p>Further company coverage: <span>2RW.MU</span></p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4007","symbol_name":"制药","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260113:nFWN3YE104:1","article_id":"2603681489","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2603681489","pubTimestamp":1768309198,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"BRIEF-Oramed And Lifeward Announce Strategic TransactionJan 13 (Reuters) - Lifeward Ltd 2RW.MU:ORAMED AND LIFEWARD ANNOUNCE STRATEGIC TRANSACTIONORAMED PHARMACEUTICALS INC - TO RECEIVE 49.9% OWNERSHIP","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4007":"制药","ORMP":"Oramed Pharmaceuticals Inc"},"translate_title":"简介-Oramed和Lifeward宣布战略交易","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ORMP":0.9},"content_text":"BRIEF-Oramed And Lifeward Announce Strategic TransactionJan 13 (Reuters) - Lifeward Ltd 2RW.MU:ORAMED AND LIFEWARD ANNOUNCE STRATEGIC TRANSACTIONORAMED PHARMACEUTICALS INC - TO RECEIVE 49.9% OWNERSHIP IN LIFEWARDORAMED PHARMACEUTICALS INC - MARK GRANT TO LEAD COMBINED PLATFORMSORAMED PHARMACEUTICALS INC - LIFEWARD TO ISSUE $10 MILLION CONVERTIBLE NOTESORAMED PHARMACEUTICALS INC - WILL RECEIVE 4% ON NET SALES OF REWALK FRANCHISE FOR UP TO 10 YEARSSource text: ID:nPnwV5H2aFurther company coverage: 2RW.MU ((Reuters.Briefs@thomsonreuters.com;))","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2603681489","isCrawlerRequest":true}